Real-world experience of emicizumab prophylaxis in young children with hemophilia a: retrospective data from china

HIGHLIGHTS

  • who: Guoqing Liu and collaborators from the (UNIVERSITY) have published the Article: Real-world experience of emicizumab prophylaxis in young children with hemophilia A: retrospective data from China, in the Journal: (JOURNAL)

SUMMARY

    @@

ACRONYMS

LAY DEFINITIONS

  • children: A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL
  • prophylaxis: Preventive healthcare consists of measures taken for disease prevention. Disease and disability are affected by environmental factors, genetic predisposition, disease agents, and lifestyle choices and are dynamic processes which . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?